SuperworthVeracyte market cap VCYT
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $3.9B
- Highest close in our data
- $4.8B
- Jun 2026
Veracyte is worth $3.9B at the close on Oct 23, 2026, at $47.93 a share.
That is up 33% over the last year and up 19% over five years.
Its highest close in our data was $4.8B in Jun 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.9B | $2.4B | $4.8B | +15% |
| 2025 | $3.4B | $1.8B | $3.7B | +8% |
| 2024 | $3.1B | $1.4B | $3.4B | +55% |
| 2023 | $2B | $1.4B | $2.1B | +18% |
| 2022 | $1.7B | $1.1B | $2.4B | −42% |
| 2021 | $2.9B | $2.2B | $4.4B | +3% |
| 2020 | $2.8B | $914.7M | $3.3B | +99% |
| 2019 | $1.4B | $577.3M | $1.4B | +188% |
| 2018 | $493.4M | $185.9M | $587M | +122% |
| 2017 | $222.3M | $207.7M | $318.5M | +3% |
| 2016 | $216.3M | $132.6M | $226.3M | +9% |
| 2015 | $199.2M | $159.2M | $328.7M | −5% |
| 2014 | $208.6M | $146.7M | $377.8M | −30% |
| 2013 | $297.6M | $273M | $297.6M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Veracyte's size, closest first, today.
| Company | Market cap |
|---|---|
| VCYTVeracyte | $3.9B |
| CDNACareDx | $3.6B |
| BLLNBillionToOne | $5.1B |
| LNTHLantheus | $6.5B |
| CAICaris Life Sciences | $9B |
| BIOBio-Rad Laboratories | $9.9B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| NRCNRC Health | $485.1M |
| Peer median | $9.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Veracyte
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.